Comparative pharmacology of the optical isomers of ketamine in mice

https://doi.org/10.1016/0014-2999(78)90217-0Get rights and content

Abstract

Relative pharmacology potencies of the optical isomers of ketamine have been estimated in ICR mice. The (+)-isomer was 3× more potent than (−)-ketamine as an analgesic using the phenylquinone writhing test, only 1.5 × more potent in terms of hypnotic activity 1.8 more potent in causing locomotor stimulation. At equianalgesic doses (+)-ketamine caused less stimulation of locomotor activity than the (−)-isomer. These potency differences did not appear to be due to differences in biodisposition although stereoselective metabolism was demonstrated in vivo. Analgesia induced by ketamine was reversed by 10 mg.kg of naloxone.

References (22)

  • L.M. Gunne et al.

    Stereoselective metabolism of amphetamine

    Biochem. Pharmacol.

    (1967)
  • P.S. Portoghese

    Stereochemical factors and receptor interactions associated with narcotic analgesics

    J. Pharm. Sci.

    (1966)
  • B.S. Berkowitz et al.

    Nitrous oxide “analgesia”: resemblence to opiate action

    Science

    (1979)
  • K. Blum et al.

    Naloxone-induced inhibition of ethanol dependence in mice

    Nature

    (1977)
  • T. Chang et al.

    A gas chromatographic assay for ketamine in human plasma

    Anesthesiology

    (1972)
  • T. Chang et al.

    Intern. Anesth. Clin.

    (1974)
  • M.L. Cohen et al.

    Distribution in the brain and metabolism of ketamine in the rat after intravenous administration

    Anesthesiology

    (1973)
  • G. Corssen et al.

    Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phenylcyclidine derivative CI-581

    Anesth. Analg.

    (1966)
  • E.F. Domino et al.

    Pharmacologic effects of CI-581, a new dissociative anesthetic, in man

    Clin. Pharmacol. Therap.

    (1965)
  • L.G. Dring et al.

    The metabolic fate of amphetamine in man and other species

    Biochem. j.

    (1970)
  • J.W. Dundee et al.

    Intravenous Anesthesia

    (1974)
  • Cited by (152)

    • Injectable anesthetics

      2023, Anesthesia and Analgesia in Laboratory Animals
    • The opioid system in depression

      2022, Neuroscience and Biobehavioral Reviews
    • Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence

      2022, Journal of the Neurological Sciences
      Citation Excerpt :

      Clinical trials of buprenorphine, a kappa-opioid receptor antagonist, demonstrate a rapid but transient anti-depressant effect (99). The analgesic effect of ketamine can be blocked by naloxone, an opioid receptor antagonist (100). Further in vitro studies found that ketamine bound to opioid receptors and displaced a radioactively labeled opioid receptor agonist (101).

    • Arylcyclohexamines

      2021, Novel Psychoactive Substances: Classification, Pharmacology and Toxicology
    • Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine

      2019, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Due to its serious side effects, clinical use of ketamine has remained limited (Domino, 2010; Sanacora et al., 2017; Singh et al., 2017; Zhu et al., 2016), although it has been used as an off-label antidepressant in the USA (Reardon, 2018; Wilkinson et al., 2017). In this study, we found that locomotion after a single intranasal administration of (R)-ketamine is lower than those of (R,S)-ketamine and (S)-ketamine, consistent with the previous reports (Ryder et al., 1978; Yang et al., 2015) of subcutaneous or i.p. administration. Furthermore, we found that a single intranasal administration of (R)-ketamine did not cause PPI deficits in mice compared to (R,S)-ketamine and (S)-ketamine, consistent with the previous reports of i.p. administration (Yang et al., 2015).

    View all citing articles on Scopus

    This is publication No. 77-25 from the Department of Pharmacology, University of California, San Francisco.

    ∗∗

    This work represents partial fulfillment of the requirements for the degree of Doctor of Philosophy.

    View full text